Stocktoria
Core Scientific, Inc./tx CORZ
Nasdaq · XNAS · stock · Finance Services · website · IPO 2021-04-05
Core Scientific, Inc./tx financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $319.0M | $510.7M | $502.4M | $640.3M | $544.5M |
| Gross profit | $37.9M | $121.1M | $123.5M | $8.4M | $238.9M |
| R&D expense | — | $11.8M | $7.2M | $27.0M | $7.7M |
| SG&A expense | $159.2M | $113.7M | $108.1M | — | — |
| Operating income | -$245.6M | -$142.1M | $9.0M | -$2.1B | $131.5M |
| Income tax | $583,000 | $859,000 | $683,000 | -$17.1M | $15.8M |
| Net income | -$288.6M | -$1.4B | -$246.5M | -$2.1B | $47.3M |
| EPS (diluted) | $-0.88 | $-4.87 | $-0.65 | $-6.30 | $0.20 |
| Operating cash flow | $278.2M | $42.9M | $65.1M | $205.2M | -$56.7M |
| Free cash flow | -$450.8M | -$52.1M | $49.0M | -$178.8M | -$56.7M |
| Cash & equivalents | $311.4M | $836.2M | $50.4M | $15.9M | $117.9M |
| Total assets | $2.3B | $1.5B | $712.2M | $807.7M | $2.4B |
| Total liabilities | $3.3B | $2.4B | $1.3B | $1.2B | $1.1B |
| Shareholders' equity | -$962.7M | -$943.0M | -$596.9M | -$409.3M | $1.3B |
Source: SEC EDGAR filings · CIK 0001839341 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.